nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA14—Furosemide—dilated cardiomyopathy	0.114	0.153	CbGbCtD
Celecoxib—CA5A—Furosemide—dilated cardiomyopathy	0.109	0.145	CbGbCtD
Celecoxib—CA6—Furosemide—dilated cardiomyopathy	0.109	0.145	CbGbCtD
Celecoxib—CA5B—Furosemide—dilated cardiomyopathy	0.0947	0.127	CbGbCtD
Celecoxib—CA12—Furosemide—dilated cardiomyopathy	0.0813	0.109	CbGbCtD
Celecoxib—CA9—Furosemide—dilated cardiomyopathy	0.0813	0.109	CbGbCtD
Celecoxib—CA4—Furosemide—dilated cardiomyopathy	0.0715	0.0956	CbGbCtD
Celecoxib—CA2—Furosemide—dilated cardiomyopathy	0.0657	0.0879	CbGbCtD
Celecoxib—ALB—Furosemide—dilated cardiomyopathy	0.0215	0.0288	CbGbCtD
Celecoxib—CA5B—sinoatrial node—dilated cardiomyopathy	0.0171	0.348	CbGeAlD
Celecoxib—CYP2C9—cardial valve—dilated cardiomyopathy	0.00874	0.178	CbGeAlD
Celecoxib—PDPK1—myocardium—dilated cardiomyopathy	0.00392	0.0799	CbGeAlD
Celecoxib—PDPK1—heart—dilated cardiomyopathy	0.00274	0.0558	CbGeAlD
Celecoxib—CA14—cardiac ventricle—dilated cardiomyopathy	0.00217	0.0442	CbGeAlD
Celecoxib—Bullous eruption—Furosemide—dilated cardiomyopathy	0.00184	0.016	CcSEcCtD
Celecoxib—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00174	0.0152	CcSEcCtD
Celecoxib—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00157	0.0137	CcSEcCtD
Celecoxib—Breast pain—Spironolactone—dilated cardiomyopathy	0.00153	0.0134	CcSEcCtD
Celecoxib—MAPK14—heart—dilated cardiomyopathy	0.00147	0.0298	CbGeAlD
Celecoxib—CA14—heart—dilated cardiomyopathy	0.00143	0.029	CbGeAlD
Celecoxib—Ulcer—Spironolactone—dilated cardiomyopathy	0.00141	0.0123	CcSEcCtD
Celecoxib—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00137	0.0119	CcSEcCtD
Celecoxib—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00123	0.0107	CcSEcCtD
Celecoxib—CA14—cardiac atrium—dilated cardiomyopathy	0.00122	0.0248	CbGeAlD
Celecoxib—Drug eruption—Furosemide—dilated cardiomyopathy	0.00118	0.0103	CcSEcCtD
Celecoxib—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00108	0.00942	CcSEcCtD
Celecoxib—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00108	0.00939	CcSEcCtD
Celecoxib—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00105	0.00916	CcSEcCtD
Celecoxib—CA4—cardiac ventricle—dilated cardiomyopathy	0.00105	0.0213	CbGeAlD
Celecoxib—CA5B—heart—dilated cardiomyopathy	0.000997	0.0203	CbGeAlD
Celecoxib—CA4—myocardium—dilated cardiomyopathy	0.000986	0.0201	CbGeAlD
Celecoxib—Cholestasis—Furosemide—dilated cardiomyopathy	0.000956	0.00835	CcSEcCtD
Celecoxib—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.000948	0.00828	CcSEcCtD
Celecoxib—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.000916	0.00799	CcSEcCtD
Celecoxib—Ataxia—Spironolactone—dilated cardiomyopathy	0.000911	0.00795	CcSEcCtD
Celecoxib—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.000903	0.00788	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000872	0.00761	CcSEcCtD
Celecoxib—CA2—cardiac ventricle—dilated cardiomyopathy	0.000869	0.0177	CbGeAlD
Celecoxib—Gastritis—Spironolactone—dilated cardiomyopathy	0.000857	0.00748	CcSEcCtD
Celecoxib—CA5B—cardiac atrium—dilated cardiomyopathy	0.000853	0.0174	CbGeAlD
Celecoxib—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000829	0.00724	CcSEcCtD
Celecoxib—CA2—myocardium—dilated cardiomyopathy	0.000818	0.0166	CbGeAlD
Celecoxib—Drug interaction—Furosemide—dilated cardiomyopathy	0.000783	0.00683	CcSEcCtD
Celecoxib—ALB—heart—dilated cardiomyopathy	0.000773	0.0157	CbGeAlD
Celecoxib—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000763	0.00666	CcSEcCtD
Celecoxib—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.000763	0.00666	CcSEcCtD
Celecoxib—Laryngitis—Lisinopril—dilated cardiomyopathy	0.000756	0.0066	CcSEcCtD
Celecoxib—ABCC4—heart—dilated cardiomyopathy	0.000749	0.0152	CbGeAlD
Celecoxib—Vasculitis—Furosemide—dilated cardiomyopathy	0.000744	0.00649	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00074	0.00646	CcSEcCtD
Celecoxib—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.000739	0.00645	CcSEcCtD
Celecoxib—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.000723	0.00632	CcSEcCtD
Celecoxib—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000711	0.00621	CcSEcCtD
Celecoxib—Otitis media—Lisinopril—dilated cardiomyopathy	0.0007	0.00611	CcSEcCtD
Celecoxib—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000697	0.00608	CcSEcCtD
Celecoxib—CA4—heart—dilated cardiomyopathy	0.000688	0.014	CbGeAlD
Celecoxib—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000682	0.00595	CcSEcCtD
Celecoxib—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000667	0.00582	CcSEcCtD
Celecoxib—Bladder pain—Furosemide—dilated cardiomyopathy	0.000656	0.00573	CcSEcCtD
Celecoxib—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000634	0.00553	CcSEcCtD
Celecoxib—Breast pain—Lisinopril—dilated cardiomyopathy	0.000624	0.00545	CcSEcCtD
Celecoxib—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00062	0.00541	CcSEcCtD
Celecoxib—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000611	0.00534	CcSEcCtD
Celecoxib—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000609	0.00531	CcSEcCtD
Celecoxib—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000606	0.00529	CcSEcCtD
Celecoxib—Viral infection—Lisinopril—dilated cardiomyopathy	0.000603	0.00526	CcSEcCtD
Celecoxib—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0006	0.00524	CcSEcCtD
Celecoxib—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000599	0.00523	CcSEcCtD
Celecoxib—Alopecia—Spironolactone—dilated cardiomyopathy	0.000592	0.00517	CcSEcCtD
Celecoxib—Deafness—Furosemide—dilated cardiomyopathy	0.000589	0.00514	CcSEcCtD
Celecoxib—CA4—cardiac atrium—dilated cardiomyopathy	0.000589	0.012	CbGeAlD
Celecoxib—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000587	0.00513	CcSEcCtD
Celecoxib—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000572	0.005	CcSEcCtD
Celecoxib—CA2—heart—dilated cardiomyopathy	0.000571	0.0116	CbGeAlD
Celecoxib—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000561	0.0049	CcSEcCtD
Celecoxib—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000559	0.00488	CcSEcCtD
Celecoxib—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000558	0.00487	CcSEcCtD
Celecoxib—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000551	0.00481	CcSEcCtD
Celecoxib—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000545	0.00476	CcSEcCtD
Celecoxib—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000545	0.00475	CcSEcCtD
Celecoxib—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000532	0.00465	CcSEcCtD
Celecoxib—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000529	0.00462	CcSEcCtD
Celecoxib—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000529	0.00462	CcSEcCtD
Celecoxib—Cystitis—Lisinopril—dilated cardiomyopathy	0.000526	0.00459	CcSEcCtD
Celecoxib—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000522	0.00456	CcSEcCtD
Celecoxib—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000517	0.00451	CcSEcCtD
Celecoxib—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000514	0.00449	CcSEcCtD
Celecoxib—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000511	0.00446	CcSEcCtD
Celecoxib—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000494	0.00431	CcSEcCtD
Celecoxib—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000493	0.0043	CcSEcCtD
Celecoxib—CA2—cardiac atrium—dilated cardiomyopathy	0.000488	0.00994	CbGeAlD
Celecoxib—CYP2C9—heart—dilated cardiomyopathy	0.000483	0.00983	CbGeAlD
Celecoxib—Confusional state—Spironolactone—dilated cardiomyopathy	0.00048	0.00419	CcSEcCtD
Celecoxib—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00048	0.00419	CcSEcCtD
Celecoxib—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000478	0.00417	CcSEcCtD
Celecoxib—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000476	0.00416	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000475	0.00414	CcSEcCtD
Celecoxib—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000466	0.00407	CcSEcCtD
Celecoxib—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000457	0.00399	CcSEcCtD
Celecoxib—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000455	0.00397	CcSEcCtD
Celecoxib—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000452	0.00395	CcSEcCtD
Celecoxib—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000451	0.00394	CcSEcCtD
Celecoxib—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00045	0.00393	CcSEcCtD
Celecoxib—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000447	0.0039	CcSEcCtD
Celecoxib—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000446	0.00389	CcSEcCtD
Celecoxib—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00044	0.00384	CcSEcCtD
Celecoxib—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000428	0.00374	CcSEcCtD
Celecoxib—Somnolence—Spironolactone—dilated cardiomyopathy	0.000423	0.00369	CcSEcCtD
Celecoxib—PTGS2—heart—dilated cardiomyopathy	0.000421	0.00858	CbGeAlD
Celecoxib—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000421	0.00367	CcSEcCtD
Celecoxib—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000416	0.00363	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000411	0.00359	CcSEcCtD
Celecoxib—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000411	0.00359	CcSEcCtD
Celecoxib—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000409	0.00357	CcSEcCtD
Celecoxib—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000405	0.00354	CcSEcCtD
Celecoxib—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000404	0.00352	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000403	0.00352	CcSEcCtD
Celecoxib—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000397	0.00347	CcSEcCtD
Celecoxib—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000395	0.00345	CcSEcCtD
Celecoxib—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000392	0.00343	CcSEcCtD
Celecoxib—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000384	0.00335	CcSEcCtD
Celecoxib—Face oedema—Lisinopril—dilated cardiomyopathy	0.000382	0.00333	CcSEcCtD
Celecoxib—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000379	0.00331	CcSEcCtD
Celecoxib—Urticaria—Spironolactone—dilated cardiomyopathy	0.000378	0.0033	CcSEcCtD
Celecoxib—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000376	0.00329	CcSEcCtD
Celecoxib—Ataxia—Lisinopril—dilated cardiomyopathy	0.000372	0.00325	CcSEcCtD
Celecoxib—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00037	0.00323	CcSEcCtD
Celecoxib—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00036	0.00314	CcSEcCtD
Celecoxib—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000357	0.00312	CcSEcCtD
Celecoxib—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000357	0.00312	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000356	0.00311	CcSEcCtD
Celecoxib—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000354	0.00309	CcSEcCtD
Celecoxib—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000351	0.00306	CcSEcCtD
Celecoxib—Gastritis—Lisinopril—dilated cardiomyopathy	0.00035	0.00305	CcSEcCtD
Celecoxib—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000345	0.00301	CcSEcCtD
Celecoxib—Eye disorder—Furosemide—dilated cardiomyopathy	0.000341	0.00297	CcSEcCtD
Celecoxib—Tinnitus—Furosemide—dilated cardiomyopathy	0.00034	0.00297	CcSEcCtD
Celecoxib—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000338	0.00295	CcSEcCtD
Celecoxib—Pruritus—Spironolactone—dilated cardiomyopathy	0.000337	0.00294	CcSEcCtD
Celecoxib—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000336	0.00293	CcSEcCtD
Celecoxib—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000335	0.00293	CcSEcCtD
Celecoxib—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000333	0.00291	CcSEcCtD
Celecoxib—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000333	0.00291	CcSEcCtD
Celecoxib—Angiopathy—Furosemide—dilated cardiomyopathy	0.000331	0.00289	CcSEcCtD
Celecoxib—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000329	0.00287	CcSEcCtD
Celecoxib—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000329	0.00287	CcSEcCtD
Celecoxib—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000326	0.00284	CcSEcCtD
Celecoxib—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000326	0.00284	CcSEcCtD
Celecoxib—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000325	0.00283	CcSEcCtD
Celecoxib—Dysuria—Lisinopril—dilated cardiomyopathy	0.00032	0.00279	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000318	0.00277	CcSEcCtD
Celecoxib—Dizziness—Spironolactone—dilated cardiomyopathy	0.000315	0.00275	CcSEcCtD
Celecoxib—Flatulence—Furosemide—dilated cardiomyopathy	0.000313	0.00273	CcSEcCtD
Celecoxib—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000312	0.00272	CcSEcCtD
Celecoxib—Weight increased—Lisinopril—dilated cardiomyopathy	0.000311	0.00272	CcSEcCtD
Celecoxib—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000311	0.00271	CcSEcCtD
Celecoxib—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000308	0.00269	CcSEcCtD
Celecoxib—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000307	0.00268	CcSEcCtD
Celecoxib—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000305	0.00266	CcSEcCtD
Celecoxib—Vomiting—Spironolactone—dilated cardiomyopathy	0.000303	0.00264	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000302	0.00264	CcSEcCtD
Celecoxib—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.0003	0.00262	CcSEcCtD
Celecoxib—Rash—Spironolactone—dilated cardiomyopathy	0.0003	0.00262	CcSEcCtD
Celecoxib—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0003	0.00262	CcSEcCtD
Celecoxib—Vision blurred—Furosemide—dilated cardiomyopathy	0.000299	0.00261	CcSEcCtD
Celecoxib—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000299	0.00261	CcSEcCtD
Celecoxib—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000299	0.00261	CcSEcCtD
Celecoxib—Headache—Spironolactone—dilated cardiomyopathy	0.000298	0.0026	CcSEcCtD
Celecoxib—Jaundice—Lisinopril—dilated cardiomyopathy	0.000297	0.00259	CcSEcCtD
Celecoxib—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000296	0.00259	CcSEcCtD
Celecoxib—Anaemia—Furosemide—dilated cardiomyopathy	0.000293	0.00256	CcSEcCtD
Celecoxib—Haematuria—Lisinopril—dilated cardiomyopathy	0.000291	0.00254	CcSEcCtD
Celecoxib—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000288	0.00252	CcSEcCtD
Celecoxib—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000287	0.00251	CcSEcCtD
Celecoxib—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000286	0.0025	CcSEcCtD
Celecoxib—Vertigo—Furosemide—dilated cardiomyopathy	0.000285	0.00249	CcSEcCtD
Celecoxib—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000284	0.00248	CcSEcCtD
Celecoxib—Leukopenia—Furosemide—dilated cardiomyopathy	0.000284	0.00248	CcSEcCtD
Celecoxib—Nausea—Spironolactone—dilated cardiomyopathy	0.000283	0.00247	CcSEcCtD
Celecoxib—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000274	0.00239	CcSEcCtD
Celecoxib—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000274	0.00239	CcSEcCtD
Celecoxib—Hallucination—Lisinopril—dilated cardiomyopathy	0.000272	0.00238	CcSEcCtD
Celecoxib—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000272	0.00237	CcSEcCtD
Celecoxib—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00027	0.00236	CcSEcCtD
Celecoxib—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000269	0.00235	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000268	0.00234	CcSEcCtD
Celecoxib—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000268	0.00234	CcSEcCtD
Celecoxib—Dry mouth—Furosemide—dilated cardiomyopathy	0.000264	0.00231	CcSEcCtD
Celecoxib—Confusional state—Furosemide—dilated cardiomyopathy	0.000261	0.00228	CcSEcCtD
Celecoxib—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000259	0.00226	CcSEcCtD
Celecoxib—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000259	0.00226	CcSEcCtD
Celecoxib—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000255	0.00223	CcSEcCtD
Celecoxib—Shock—Furosemide—dilated cardiomyopathy	0.000255	0.00222	CcSEcCtD
Celecoxib—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000254	0.00222	CcSEcCtD
Celecoxib—Flushing—Lisinopril—dilated cardiomyopathy	0.000254	0.00222	CcSEcCtD
Celecoxib—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000254	0.00221	CcSEcCtD
Celecoxib—Skin disorder—Furosemide—dilated cardiomyopathy	0.000252	0.0022	CcSEcCtD
Celecoxib—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00025	0.00219	CcSEcCtD
Celecoxib—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000248	0.00217	CcSEcCtD
Celecoxib—Anorexia—Furosemide—dilated cardiomyopathy	0.000247	0.00216	CcSEcCtD
Celecoxib—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000247	0.00215	CcSEcCtD
Celecoxib—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000244	0.00213	CcSEcCtD
Celecoxib—Alopecia—Lisinopril—dilated cardiomyopathy	0.000242	0.00211	CcSEcCtD
Celecoxib—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00024	0.00209	CcSEcCtD
Celecoxib—Flatulence—Lisinopril—dilated cardiomyopathy	0.000235	0.00205	CcSEcCtD
Celecoxib—Tension—Lisinopril—dilated cardiomyopathy	0.000234	0.00204	CcSEcCtD
Celecoxib—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000233	0.00204	CcSEcCtD
Celecoxib—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000233	0.00203	CcSEcCtD
Celecoxib—Nervousness—Lisinopril—dilated cardiomyopathy	0.000231	0.00202	CcSEcCtD
Celecoxib—Back pain—Lisinopril—dilated cardiomyopathy	0.00023	0.00201	CcSEcCtD
Celecoxib—Somnolence—Furosemide—dilated cardiomyopathy	0.00023	0.00201	CcSEcCtD
Celecoxib—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000229	0.002	CcSEcCtD
Celecoxib—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000225	0.00197	CcSEcCtD
Celecoxib—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000224	0.00196	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000224	0.00195	CcSEcCtD
Celecoxib—Fatigue—Furosemide—dilated cardiomyopathy	0.000223	0.00195	CcSEcCtD
Celecoxib—Constipation—Furosemide—dilated cardiomyopathy	0.000222	0.00193	CcSEcCtD
Celecoxib—Anaemia—Lisinopril—dilated cardiomyopathy	0.00022	0.00192	CcSEcCtD
Celecoxib—Angioedema—Lisinopril—dilated cardiomyopathy	0.000218	0.0019	CcSEcCtD
Celecoxib—Vertigo—Lisinopril—dilated cardiomyopathy	0.000214	0.00187	CcSEcCtD
Celecoxib—Syncope—Lisinopril—dilated cardiomyopathy	0.000214	0.00186	CcSEcCtD
Celecoxib—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000213	0.00186	CcSEcCtD
Celecoxib—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000213	0.00186	CcSEcCtD
Celecoxib—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000212	0.00185	CcSEcCtD
Celecoxib—Palpitations—Lisinopril—dilated cardiomyopathy	0.00021	0.00184	CcSEcCtD
Celecoxib—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000209	0.00183	CcSEcCtD
Celecoxib—Cough—Lisinopril—dilated cardiomyopathy	0.000208	0.00181	CcSEcCtD
Celecoxib—Urticaria—Furosemide—dilated cardiomyopathy	0.000206	0.0018	CcSEcCtD
Celecoxib—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000205	0.00179	CcSEcCtD
Celecoxib—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000205	0.00179	CcSEcCtD
Celecoxib—Chest pain—Lisinopril—dilated cardiomyopathy	0.000203	0.00177	CcSEcCtD
Celecoxib—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000203	0.00177	CcSEcCtD
Celecoxib—Myalgia—Lisinopril—dilated cardiomyopathy	0.000203	0.00177	CcSEcCtD
Celecoxib—Anxiety—Lisinopril—dilated cardiomyopathy	0.000202	0.00176	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000201	0.00176	CcSEcCtD
Celecoxib—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000198	0.00173	CcSEcCtD
Celecoxib—Confusional state—Lisinopril—dilated cardiomyopathy	0.000196	0.00171	CcSEcCtD
Celecoxib—Oedema—Lisinopril—dilated cardiomyopathy	0.000194	0.0017	CcSEcCtD
Celecoxib—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000194	0.0017	CcSEcCtD
Celecoxib—Infection—Lisinopril—dilated cardiomyopathy	0.000193	0.00169	CcSEcCtD
Celecoxib—Shock—Lisinopril—dilated cardiomyopathy	0.000191	0.00167	CcSEcCtD
Celecoxib—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000191	0.00167	CcSEcCtD
Celecoxib—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00019	0.00166	CcSEcCtD
Celecoxib—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00019	0.00166	CcSEcCtD
Celecoxib—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000189	0.00165	CcSEcCtD
Celecoxib—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000188	0.00164	CcSEcCtD
Celecoxib—Asthenia—Furosemide—dilated cardiomyopathy	0.000186	0.00162	CcSEcCtD
Celecoxib—Anorexia—Lisinopril—dilated cardiomyopathy	0.000185	0.00162	CcSEcCtD
Celecoxib—Pruritus—Furosemide—dilated cardiomyopathy	0.000183	0.0016	CcSEcCtD
Celecoxib—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000177	0.00155	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000177	0.00155	CcSEcCtD
Celecoxib—Insomnia—Lisinopril—dilated cardiomyopathy	0.000176	0.00153	CcSEcCtD
Celecoxib—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000175	0.00152	CcSEcCtD
Celecoxib—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000173	0.00151	CcSEcCtD
Celecoxib—Somnolence—Lisinopril—dilated cardiomyopathy	0.000173	0.00151	CcSEcCtD
Celecoxib—Dizziness—Furosemide—dilated cardiomyopathy	0.000171	0.0015	CcSEcCtD
Celecoxib—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000171	0.00149	CcSEcCtD
Celecoxib—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000169	0.00147	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000168	0.00146	CcSEcCtD
Celecoxib—Fatigue—Lisinopril—dilated cardiomyopathy	0.000168	0.00146	CcSEcCtD
Celecoxib—Constipation—Lisinopril—dilated cardiomyopathy	0.000166	0.00145	CcSEcCtD
Celecoxib—Vomiting—Furosemide—dilated cardiomyopathy	0.000165	0.00144	CcSEcCtD
Celecoxib—Rash—Furosemide—dilated cardiomyopathy	0.000163	0.00143	CcSEcCtD
Celecoxib—Dermatitis—Furosemide—dilated cardiomyopathy	0.000163	0.00142	CcSEcCtD
Celecoxib—Headache—Furosemide—dilated cardiomyopathy	0.000162	0.00142	CcSEcCtD
Celecoxib—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00016	0.0014	CcSEcCtD
Celecoxib—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000159	0.00139	CcSEcCtD
Celecoxib—Urticaria—Lisinopril—dilated cardiomyopathy	0.000154	0.00135	CcSEcCtD
Celecoxib—Nausea—Furosemide—dilated cardiomyopathy	0.000154	0.00134	CcSEcCtD
Celecoxib—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000154	0.00134	CcSEcCtD
Celecoxib—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000154	0.00134	CcSEcCtD
Celecoxib—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000143	0.00125	CcSEcCtD
Celecoxib—Asthenia—Lisinopril—dilated cardiomyopathy	0.000139	0.00122	CcSEcCtD
Celecoxib—Pruritus—Lisinopril—dilated cardiomyopathy	0.000138	0.0012	CcSEcCtD
Celecoxib—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000133	0.00116	CcSEcCtD
Celecoxib—Dizziness—Lisinopril—dilated cardiomyopathy	0.000129	0.00112	CcSEcCtD
Celecoxib—Vomiting—Lisinopril—dilated cardiomyopathy	0.000124	0.00108	CcSEcCtD
Celecoxib—Rash—Lisinopril—dilated cardiomyopathy	0.000123	0.00107	CcSEcCtD
Celecoxib—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000122	0.00107	CcSEcCtD
Celecoxib—Headache—Lisinopril—dilated cardiomyopathy	0.000122	0.00106	CcSEcCtD
Celecoxib—Nausea—Lisinopril—dilated cardiomyopathy	0.000115	0.00101	CcSEcCtD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—RAF1—dilated cardiomyopathy	7.23e-05	0.000814	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	7.21e-05	0.000812	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	7.19e-05	0.000809	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	7.14e-05	0.000805	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	7.12e-05	0.000802	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—EGFR—dilated cardiomyopathy	7.1e-05	0.0008	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	7.09e-05	0.000799	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	7.08e-05	0.000797	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	7.07e-05	0.000796	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.89e-05	0.000776	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.88e-05	0.000775	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	6.86e-05	0.000773	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signal transduction—EGFR—dilated cardiomyopathy	6.77e-05	0.000763	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.75e-05	0.000761	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR—EGFR—dilated cardiomyopathy	6.74e-05	0.000759	CbGpPWpGaD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	6.74e-05	0.000759	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—RAF1—dilated cardiomyopathy	6.72e-05	0.000757	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB2—EGFR—dilated cardiomyopathy	6.71e-05	0.000756	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—EGFR—dilated cardiomyopathy	6.68e-05	0.000752	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.65e-05	0.000749	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.65e-05	0.000749	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	6.58e-05	0.000741	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.46e-05	0.000728	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—ITGB1—dilated cardiomyopathy	6.41e-05	0.000722	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	6.38e-05	0.000718	CbGpPWpGaD
Celecoxib—PDPK1—Neuronal System—RAF1—dilated cardiomyopathy	6.36e-05	0.000717	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	6.34e-05	0.000714	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—CD36—dilated cardiomyopathy	6.33e-05	0.000713	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—EGFR—dilated cardiomyopathy	6.28e-05	0.000707	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	6.28e-05	0.000707	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	6.28e-05	0.000707	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PSEN2—dilated cardiomyopathy	6.28e-05	0.000707	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—RAF1—dilated cardiomyopathy	6.24e-05	0.000703	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR—EGFR—dilated cardiomyopathy	6.22e-05	0.000701	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.18e-05	0.000697	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	6.17e-05	0.000695	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by PDGF—EGFR—dilated cardiomyopathy	6.14e-05	0.000692	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	6.13e-05	0.00069	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.04e-05	0.00068	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.04e-05	0.00068	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—RAF1—dilated cardiomyopathy	6.02e-05	0.000678	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	6.01e-05	0.000677	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.99e-05	0.000675	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—RAC1—dilated cardiomyopathy	5.96e-05	0.000671	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—SOD2—dilated cardiomyopathy	5.95e-05	0.000671	CbGpPWpGaD
Celecoxib—PDPK1—Focal Adhesion—EGFR—dilated cardiomyopathy	5.93e-05	0.000668	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NPPA—dilated cardiomyopathy	5.93e-05	0.000668	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.84e-05	0.000657	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—EGFR—dilated cardiomyopathy	5.81e-05	0.000655	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PSEN2—dilated cardiomyopathy	5.74e-05	0.000646	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CD36—dilated cardiomyopathy	5.69e-05	0.000642	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—GPX1—dilated cardiomyopathy	5.68e-05	0.00064	CbGpPWpGaD
Celecoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	5.64e-05	0.000636	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.63e-05	0.000634	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.62e-05	0.000633	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—RAF1—dilated cardiomyopathy	5.61e-05	0.000632	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	5.56e-05	0.000627	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD36—dilated cardiomyopathy	5.47e-05	0.000616	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	5.46e-05	0.000615	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.44e-05	0.000613	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TTN—dilated cardiomyopathy	5.38e-05	0.000606	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—RAC1—dilated cardiomyopathy	5.37e-05	0.000605	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.29e-05	0.000596	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NR3C2—dilated cardiomyopathy	5.28e-05	0.000595	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—RAF1—dilated cardiomyopathy	5.16e-05	0.000581	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—RAC1—dilated cardiomyopathy	5.15e-05	0.000581	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.11e-05	0.000576	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	5.11e-05	0.000575	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	4.96e-05	0.000559	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—RAC1—dilated cardiomyopathy	4.89e-05	0.000551	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.85e-05	0.000547	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—dilated cardiomyopathy	4.83e-05	0.000544	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	4.67e-05	0.000526	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.66e-05	0.000525	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.64e-05	0.000523	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.56e-05	0.000514	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	4.55e-05	0.000513	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.53e-05	0.00051	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.53e-05	0.00051	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.48e-05	0.000504	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.41e-05	0.000496	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	4.4e-05	0.000496	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.4e-05	0.000496	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	4.35e-05	0.00049	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.31e-05	0.000486	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—EGFR—dilated cardiomyopathy	4.28e-05	0.000482	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	4.22e-05	0.000475	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.21e-05	0.000475	CbGpPWpGaD
Celecoxib—CA14—Metabolism—GPX1—dilated cardiomyopathy	4.18e-05	0.00047	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—GPX1—dilated cardiomyopathy	4.07e-05	0.000458	CbGpPWpGaD
Celecoxib—CA6—Metabolism—GPX1—dilated cardiomyopathy	4.07e-05	0.000458	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CD36—dilated cardiomyopathy	4.07e-05	0.000458	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.02e-05	0.000453	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.98e-05	0.000449	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VCL—dilated cardiomyopathy	3.97e-05	0.000447	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CD36—dilated cardiomyopathy	3.96e-05	0.000446	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CD36—dilated cardiomyopathy	3.96e-05	0.000446	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—RAF1—dilated cardiomyopathy	3.95e-05	0.000445	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—ITGB1—dilated cardiomyopathy	3.93e-05	0.000443	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ITGB1—dilated cardiomyopathy	3.89e-05	0.000438	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ITGB1—dilated cardiomyopathy	3.85e-05	0.000434	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GPX1—dilated cardiomyopathy	3.8e-05	0.000428	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	3.78e-05	0.000426	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—dilated cardiomyopathy	3.77e-05	0.000425	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.77e-05	0.000424	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	3.75e-05	0.000423	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CD36—dilated cardiomyopathy	3.7e-05	0.000417	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AGT—dilated cardiomyopathy	3.66e-05	0.000412	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.6e-05	0.000405	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AGT—dilated cardiomyopathy	3.57e-05	0.000402	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AGT—dilated cardiomyopathy	3.57e-05	0.000402	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.57e-05	0.000402	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.57e-05	0.000402	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	3.56e-05	0.000401	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—RAF1—dilated cardiomyopathy	3.56e-05	0.000401	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	3.54e-05	0.000399	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	3.54e-05	0.000398	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GPX1—dilated cardiomyopathy	3.52e-05	0.000396	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	3.5e-05	0.000395	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	3.47e-05	0.000391	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CD36—dilated cardiomyopathy	3.43e-05	0.000386	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.42e-05	0.000385	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—RAF1—dilated cardiomyopathy	3.42e-05	0.000385	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	3.4e-05	0.000383	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CD36—dilated cardiomyopathy	3.35e-05	0.000377	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AGT—dilated cardiomyopathy	3.33e-05	0.000375	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.32e-05	0.000374	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD36—dilated cardiomyopathy	3.32e-05	0.000374	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NPPA—dilated cardiomyopathy	3.32e-05	0.000374	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	3.3e-05	0.000371	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—CD36—dilated cardiomyopathy	3.29e-05	0.00037	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.27e-05	0.000368	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—RAF1—dilated cardiomyopathy	3.24e-05	0.000365	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	3.24e-05	0.000365	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	3.22e-05	0.000363	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.21e-05	0.000362	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—RAC1—dilated cardiomyopathy	3.16e-05	0.000356	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—RAC1—dilated cardiomyopathy	3.13e-05	0.000352	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	3.11e-05	0.00035	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—RAC1—dilated cardiomyopathy	3.1e-05	0.000349	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AGT—dilated cardiomyopathy	3.09e-05	0.000348	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.07e-05	0.000346	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	3.06e-05	0.000345	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD36—dilated cardiomyopathy	2.96e-05	0.000333	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.92e-05	0.000329	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	2.89e-05	0.000326	CbGpPWpGaD
Celecoxib—PDPK1—Disease—RAC1—dilated cardiomyopathy	2.89e-05	0.000325	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	2.88e-05	0.000325	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TAZ—dilated cardiomyopathy	2.88e-05	0.000324	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.86e-05	0.000322	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	2.81e-05	0.000317	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GPX1—dilated cardiomyopathy	2.81e-05	0.000316	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—RAC1—dilated cardiomyopathy	2.79e-05	0.000314	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	2.75e-05	0.000309	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.74e-05	0.000309	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CD36—dilated cardiomyopathy	2.73e-05	0.000308	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GPX1—dilated cardiomyopathy	2.69e-05	0.000303	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CD36—dilated cardiomyopathy	2.62e-05	0.000295	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SDHA—dilated cardiomyopathy	2.6e-05	0.000293	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.6e-05	0.000293	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	2.53e-05	0.000285	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.51e-05	0.000282	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AGT—dilated cardiomyopathy	2.46e-05	0.000277	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—dilated cardiomyopathy	2.44e-05	0.000275	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.38e-05	0.000268	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AGT—dilated cardiomyopathy	2.36e-05	0.000266	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.36e-05	0.000265	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	2.35e-05	0.000264	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—dilated cardiomyopathy	2.34e-05	0.000264	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.27e-05	0.000256	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GPX1—dilated cardiomyopathy	2.27e-05	0.000255	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.24e-05	0.000252	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—dilated cardiomyopathy	2.22e-05	0.00025	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CD36—dilated cardiomyopathy	2.21e-05	0.000249	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.15e-05	0.000242	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.13e-05	0.00024	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—RAF1—dilated cardiomyopathy	2.09e-05	0.000236	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.09e-05	0.000235	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—RAF1—dilated cardiomyopathy	2.07e-05	0.000233	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	2.06e-05	0.000232	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—RAF1—dilated cardiomyopathy	2.05e-05	0.000231	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.03e-05	0.000229	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.02e-05	0.000228	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ITGB1—dilated cardiomyopathy	2.02e-05	0.000228	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.99e-05	0.000224	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AGT—dilated cardiomyopathy	1.99e-05	0.000224	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NPPA—dilated cardiomyopathy	1.97e-05	0.000222	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.96e-05	0.000221	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.96e-05	0.000221	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AGT—dilated cardiomyopathy	1.93e-05	0.000218	CbGpPWpGaD
Celecoxib—PDPK1—Disease—RAF1—dilated cardiomyopathy	1.91e-05	0.000216	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.91e-05	0.000215	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PSEN2—dilated cardiomyopathy	1.91e-05	0.000215	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.87e-05	0.00021	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.85e-05	0.000209	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.85e-05	0.000209	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—RAF1—dilated cardiomyopathy	1.85e-05	0.000208	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.72e-05	0.000194	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD36—dilated cardiomyopathy	1.72e-05	0.000194	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.72e-05	0.000194	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.7e-05	0.000191	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.67e-05	0.000188	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.65e-05	0.000186	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RAC1—dilated cardiomyopathy	1.62e-05	0.000183	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.6e-05	0.00018	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.59e-05	0.000179	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.56e-05	0.000175	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.55e-05	0.000175	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.55e-05	0.000174	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—dilated cardiomyopathy	1.44e-05	0.000162	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.43e-05	0.000161	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—dilated cardiomyopathy	1.42e-05	0.00016	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.41e-05	0.000158	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.39e-05	0.000157	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—dilated cardiomyopathy	1.37e-05	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.35e-05	0.000152	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.34e-05	0.000151	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—dilated cardiomyopathy	1.31e-05	0.000148	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.3e-05	0.000146	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—dilated cardiomyopathy	1.27e-05	0.000143	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.27e-05	0.000143	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.16e-05	0.000131	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.14e-05	0.000128	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RAF1—dilated cardiomyopathy	1.08e-05	0.000121	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.06e-05	0.00012	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RAC1—dilated cardiomyopathy	1.05e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGT—dilated cardiomyopathy	1e-05	0.000113	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RAC1—dilated cardiomyopathy	9.58e-06	0.000108	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.19e-06	0.000104	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.19e-06	0.000104	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	8.74e-06	9.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CD36—dilated cardiomyopathy	8.51e-06	9.59e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGT—dilated cardiomyopathy	7.67e-06	8.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—dilated cardiomyopathy	7.39e-06	8.32e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—dilated cardiomyopathy	7.07e-06	7.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RAF1—dilated cardiomyopathy	6.96e-06	7.84e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CD36—dilated cardiomyopathy	6.89e-06	7.76e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RAF1—dilated cardiomyopathy	6.35e-06	7.16e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGT—dilated cardiomyopathy	6.2e-06	6.99e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	5.84e-06	6.58e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.79e-06	6.52e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	5.69e-06	6.41e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.64e-06	6.35e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	5.12e-06	5.77e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.08e-06	5.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—dilated cardiomyopathy	4.78e-06	5.38e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—dilated cardiomyopathy	4.36e-06	4.91e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.82e-06	4.3e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.72e-06	4.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.35e-06	3.77e-05	CbGpPWpGaD
